DNM1L and neoplasm: Treatment with Mdivi-1 did not inhibit tumor growth (Supplementary Fig. 1A–C), indicating that the anti-tumor effects of DRP-1 inhibition (Mdivi-1 treatment) are dependent on the presence of lymphocytes.